US Patent 7786085 Method for treating a patient undergoing chemotherapy

Patent 7786085 was granted and assigned to University of Southern California on August, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 31 Oct, 2023

"Add patent abstract"

Golden AI

edited on 31 Oct, 2023

Edits made to:

Article (+598 characters)

Article

Patent abstract

The present invention provides improved methods, kits, and pharmaceutical compositions for increasing hematopoietic cell survival and/or reducing or preventing the side effects of chemotherapy, and mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood following chemotherapy, comprising administering an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists to a patient in need of chemotherapy.

Edits on 18 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 18 Sep, 2023

Edits made to:

Infobox (+2 properties)

Infobox

Patent Inventor Names

Gere DiZerega0

Kathleen Rodgers0

Edits on 21 May, 2023

"Remove website redirecting to Patent Public Search front page"